Pharmacokinetics, mass balance, and metabolism of [14C]envonalkib (TQ-B3139), a novel ALK tyrosine kinase inhibitor, in healthy Chinese subjects

ConclusionEnvonalkib was extensively metabolized prior to excretion and eliminated primarily as metabolites via feces.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research